Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - glycopyrronium bromide - powder for solution for iontophoresis - 1mg/1mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - glycopyrronium bromide, quantity: 0.2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - 1.as a preoperative antimuscarinic to reduce salivary, tracheobronchial and pharyngeal secretions, and to reduce the acidity and volume of the gastric contents. 2.as a preoperative or intraoperative antimuscarinic to attenuate or prevent intraoperative bradycardia associated with the use of suxa-methonium or due to cardiac vagal reflexes. 3.to protect against the peripheral muscarinic actions (eg. bradycardia and excessive secretions) of anticholinesterases such as neostigmine or pyridostigmine given to reverse neuromuscular blockade produced by nondepolarising muscle relaxants.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - glycopyrronium bromide (glycopyrrolate) -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

novartis corporation (malaysia) sdn. bhd. - glycopyrronium bromide; mometasone furoate; indacaterol acetate -

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - glycopyrronium bromide 63ug equivalent to glycopyrronium 50 mcg;  ; indacaterol maleate 143ug equivalent to indacaterol 110 mcg;   - powder filled inhalation capsule - 110/50mcg - active: glycopyrronium bromide 63ug equivalent to glycopyrronium 50 mcg   indacaterol maleate 143ug equivalent to indacaterol 110 mcg   excipient: carrageenan hypromellose lactose monohydrate magnesium stearate potassium chloride purified water tartrazine - ultibro breezhaler 110/50 is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in patients with chronic obstructive pulmonary disease (copd), and for the reduction of exacerbations of copd in patients with a history of exacerbations.

Malta - engelsk - Malta Medicines Authority

macarthys laboratories limited - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 microgram(s)/millilitre - drugs for functional gastrointestinal disorders

Malta - engelsk - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders

Malta - engelsk - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders

Malta - engelsk - Malta Medicines Authority

central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders

Malta - engelsk - Malta Medicines Authority

health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders